Chronic Hypertension & Delivery: Timing Guide
- A recent study from the University of cincinnati College of medicine suggests that 39 weeks is the ideal gestation period for delivery in pregnant women with chronic hypertension.
- Robert Rossi, analyzed data from 227,000 women using U.S.
- Chronic hypertension, affecting 3% to 10% of pregnant women, can lead to complications such as preeclampsia, preterm birth, stillbirth, low birth weight, and newborn death.
For expectant mothers, this News Directory 3 article unpacks an vital new study that pinpoints 39 weeks as the optimal delivery time when chronic hypertension is a factor.Researchers discovered this timing balances risks, as current guidelines suggesting delivery between 37 and 39 weeks don’t have as strong evidence. The study, the most expansive of its kind, analyzed data from over 227,000 women, illuminating the impact of chronic hypertension—a vascular disorder impacting uterine and placental blood flow—on both mother and baby. This critical finding offers new insights for managing the potential for preeclampsia and other complications. Determine your ideal delivery time and discover how to improve outcomes. What’s ahead for mothers medicated for the condition?
Study Pinpoints Optimal Delivery time for pregnancies Elaborate by Chronic Hypertension
Updated June 06, 2025
A recent study from the University of cincinnati College of medicine suggests that 39 weeks is the ideal gestation period for delivery in pregnant women with chronic hypertension. The research, published in O&G Open, challenges current guidelines that recommend delivery between 37 and 39 weeks, arguing those recommendations lack robust evidence.
The study, led by Dr. Robert Rossi, analyzed data from 227,000 women using U.S. Centers for Disease Control and Prevention birth records from 2014 to 2018. This makes it the largest study to date examining delivery timing in pregnant mothers with chronic hypertension, a important vascular disorder affecting blood flow to the uterus and placenta.
Chronic hypertension, affecting 3% to 10% of pregnant women, can lead to complications such as preeclampsia, preterm birth, stillbirth, low birth weight, and newborn death. The research indicates that while avoiding pregnancies past 39 weeks is crucial, early-term births before 39 weeks should also be avoided unless other complications arise. Finding the optimal delivery time is essential for improving maternal and infant outcomes.
The study also found that the optimal delivery time of 39 weeks holds true for African American women, who are disproportionately affected by chronic hypertension during pregnancy and face a higher risk of stillbirth and infant death. The findings underscore the importance of tailored care and monitoring for this high-risk group.
“This study has widespread relevance as it used a large-scale data set that encompassed all births in the U.S. in the given time frame to provide data-driven recommendations for delivery timing among women with chronic hypertension,” said Rossi, associate professor in the Department of Obstetrics and Gynecology.
“For every roughly 100 patients with chronic hypertension who deliver at 39 weeks instead of 40 weeks, we would expect to see one less stillbirth, infant death or adverse newborn outcome,” Rossi said.
What’s next
Rossi noted that future research should focus on pregnant women medicated for chronic hypertension to determine if the 39-week proposal remains optimal or if earlier delivery is more beneficial for this specific group. Further studies will help refine guidelines and improve outcomes for mothers and infants affected by chronic hypertension during pregnancy.